News – Page 111 – Endpoints News

Updated: NIH says SIGA’s antiviral didn’t improve resolution in mpox lesions in the DRC

9 months ago

Updated: Federal government reveals negotiated prices under Inflation Reduction Act

9 months ago

In a reality check for the field, AI underwhelms in Leash Bio's binding contest: 'No one did well'

9 months ago

Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings

9 months ago

Zealand joins next-gen club aiming to ‘accelerate’ obesity drug development

9 months ago

Incyte gets another graft-versus-host disease drug approval, this time with partner Syndax

9 months ago

FDA warning letter targets doctor who worked on a Takeda Phase 3 study

9 months ago

Bluebird's slow sickle cell launch forces rework of loan, putting cash runway at risk

9 months ago

Arrowhead lays out early-stage obesity strategy, including new target on fat-storing cells

9 months ago

Investment in early-stage health tech startups climbed in the first half of 2024, report shows

9 months ago

Gilead wins FDA accelerated approval of seladelpar after acquiring it in $4.3B deal

9 months ago

Sanofi backs AnaptysBio’s $100M offering, helping catapult the biotech’s stock

9 months ago

Verrica’s stock dips despite Phase 2 skin cancer drug clearing more than 50% of lesions

9 months ago

Evotec to cut 400 workers and close sites, citing ‘no new signals of recovery’ this year

9 months ago

Another offering for Avidity; Galera shuts down

9 months ago

Avenge Bio, a cell therapy biotech from Rice, is closed

9 months ago

Metagenomi tinkers with pipeline after CSO departure, says Affini-T and Ionis pacts are progressing

9 months ago

AstraZeneca's Imfinzi, Lynparza combo approved in EU for certain endometrial cancer patients

9 months ago

In bid to save cash, Grail says it will cut 350 jobs and focus on multi-cancer test

9 months ago

To get back to growth, Illumina CEO says it's simplifying DNA sequencing and analysis

9 months ago

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

9 months ago

Lilly opens huge new Boston research center, with a focus on genetic medicines

9 months ago

Past and present FDA adcomm members weigh in on potential reforms

9 months ago

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

9 months ago

First page Previous page 108 109 110111112 113 114 Next page Last page